Finance Watch: Sutro Halves Workforce, Cuts Lead ADC And CEO Moves On
Earnings Season Brings Cost Cuts, Layoffs
Restructuring Edition: Biopharma companies used fourth-quarter updates to reveal job and program cuts to conserve cash, including Sutro, Agenus, Coherus, Inozyme and Atea. Also, Vincerx’s reverse merger was terminated and Vaccinex, Oncternal, Syros plan to voluntarily delist.
